Skip to main content
. 2020 Jun 19;10:9989. doi: 10.1038/s41598-020-66866-1

Figure 4.

Figure 4

SPME-GC-MS analysis of terpene products from assays with recombinant TPS enzymes. Partially purified proteins were incubated in the presence of GDP or (E,E)-FDP. 1: β-myrcene*, 2: limonene*, 3: α-terpinolene*, 4: (Z)-β-ocimene*, 5: (E)-β-ocimene*, 6: γ-terpinene*, 7: linalool*, 8: α-phellandrene*, 9: α-pinene*, 10: sabinene*, 11: α-terpineol*, 12: germacrene D*, 13: β-elemene, 14: δ-elemene, 15: nerolidol*, 16: (E)-α-bergamotene*, 17: (E)-β-farnesene*, 18: (Z)-α-bisabolene*, 19: β-bisabolene*, 20: sesquiphellandrene*, 21: (E)-α-bisabolene*. *indicates compounds that were identified with authentic standards or by comparison with compounds of Opopanax oil. Other compounds were identified by library comparison only (≥95% confidence level). Mass spectra of these compounds are shown in Supplementary Figure S12. Lower case letters indicate additional terpene compounds with lower identification confidence levels. Mass spectra of these compounds are depicted in Supplementary Figure S13. Note that retention times of products obtained from TPS-a enzymes with GDP are shifted by 1 min due to difference in column condition. B; SPME fiber-related background occurring in some assays.